Press Releases
Quaker Chemical Announces Fourth Quarter And Full Year 2013 Results
Mr. Barry continued, "2013 was another very good year for Quaker in terms of revenue, net income, net operating cash flow, and adjusted EBITDA despite a challenging global economy. Also, our shareholder value creation was 45% as we continued with both dividend and share price appreciation. We closed the quarter with a positive net cash/debt position and successfully upsized our bank facility to
Mr. Barry also noted, "Going into 2014, we expect to see modest market growth in all regions of the world which is a change considering that the global markets have been uneven for the past few years. However, we continue to operate in a competitive environment with some challenging economic conditions and also could incur some increases in raw material costs from current levels. On the other hand, I continue to expect market share gains from our strategic initiatives and recent acquisitions which will build upon the anticipated end market growth. On balance, I remain confident in our future and expect 2014 to be another good year for Quaker as we strive to increase revenue and earnings for the fifth consecutive year."
Fourth Quarter of 2013 Summary
Net sales for the fourth quarter of 2013 of
Gross profit increased approximately
Selling, general and administrative expenses ("SG&A") increased
The decrease in other income of
Interest expense was lower in the fourth quarter of 2013 compared to the fourth quarter of 2012, primarily due to decreases in average borrowings and interest rates. Interest income was higher in the fourth quarter of 2013 compared to the fourth quarter of 2012, primarily due to an increase in the level of the Company's cash on hand.
The Company's effective tax rates for the fourth quarters of 2013 and 2012 were 21.7% and 18.2%, respectively. The primary contributors to the increase in the current quarter's effective tax rate were lower changes in reserves related to uncertain tax positions and certain one-time discrete items that decreased the fourth quarter of 2012 effective tax rate, partially offset by a change in the mix of income to lower tax jurisdictions in the fourth quarter of 2013.
The increase in equity in net income of associated companies from the fourth quarter of 2012 was primarily due to higher earnings related to the Company's equity interest in a captive insurance company.
Year-to-Date Summary
Net sales for 2013 of
Gross profit increased by approximately
SG&A increased approximately
Other income in 2013 was generally consistent with 2012. In 2013, the Company recorded other income from a refund related to past excise taxes paid on certain mineral oil sales, which was offset by higher other income in 2012 from changes in the fair value of certain contingent consideration liabilities related to past acquisitions.
The decrease in interest expense from 2012 to 2013 was primarily due to lower average borrowings and lower interest rates in 2013. The increase in interest income from 2012 to 2013 was primarily due to a higher level of the Company's cash on hand.
The Company's effective tax rates for 2013 and 2012 were 28.1% and 24.7%, respectively. The primary contributors to the increase in the current year's effective tax rate were lower changes in reserves related to uncertain tax positions and certain one-time discrete items that decreased the 2012 effective tax rate, partially offset by a change in the mix of income to lower tax jurisdictions during 2013.
The increase in equity in net income of associated companies from 2012 was primarily due to higher earnings related to the Company's equity interest in a captive insurance company during 2013, including a non-cash out-of-period adjustment recorded in 2013. Partially offsetting this increase in equity in net income of associated companies was a charge recorded in 2013 due to the devaluation of the Venezuelan Bolivar Fuerte.
Changes in foreign exchange rates negatively impacted 2013 net income by approximately
Balance Sheet and Cash Flow Items
The Company's net operating cash flow for the fourth quarter of 2013 was
Non-GAAP Measures
Included in this public release are non-GAAP financial measures of non-GAAP earnings per diluted share and adjusted EBITDA. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP. The following are reconciliations between the non-GAAP (unaudited) financial measures of non-GAAP earnings per diluted share and adjusted EBITDA to their most directly comparable GAAP financial measures:
Three Months Ended December 31, |
Twelve Months Ended December 31, |
|||||||
2013 |
2012 |
2013 |
2012 |
|||||
GAAP earnings per diluted share attributable to Quaker Chemical Corporation Common Shareholders |
$ 1.07 |
$ 0.99 |
$ 4.27 |
$ 3.63 |
||||
Equity income in a captive insurance company per diluted share |
(0.08) |
(0.03) |
(0.41) |
(0.14) |
||||
Mineral oil excise tax refund per diluted share |
— |
— |
(0.14) |
— |
||||
Change in acquisition-related earnout liability per diluted share |
(0.06) |
(0.09) |
(0.03) |
(0.09) |
||||
Cost streamlining initiatives per diluted share |
0.01 |
— |
0.08 |
— |
||||
Devaluation of the Venezuelan Bolivar Fuerte per diluted share |
— |
— |
0.03 |
— |
||||
Non-income tax contingency charge per diluted share |
0.04 |
— |
0.04 |
— |
||||
Customer bankruptcy costs per diluted share |
— |
— |
— |
0.06 |
||||
CFO transition costs per diluted share |
— |
— |
— |
0.03 |
||||
Non-GAAP earnings per diluted share |
$ 0.98 |
$ 0.87 |
$ 3.84 |
$ 3.49 |
Three Months Ended December 31, |
Twelve Months Ended December 31, |
|||||||
2013 |
2012 |
2013 |
2012 |
|||||
Net income attributable to Quaker Chemical Corporation |
$ 14,086 |
$ 13,007 |
$ 56,339 |
$ 47,405 |
||||
Depreciation and amortization |
3,944 |
4,074 |
15,784 |
15,358 |
||||
Interest expense |
699 |
924 |
2,922 |
4,283 |
||||
Tax expense |
3,556 |
2,883 |
20,489 |
15,575 |
||||
Equity income in a captive insurance company |
(1,073) |
(386) |
(5,451) |
(1,812) |
||||
Mineral oil excise tax refund |
— |
— |
(2,540) |
— |
||||
Change in acquisition-related earnout liability |
(1,172) |
(1,737) |
(497) |
(1,737) |
||||
Cost streamlining initiatives |
142 |
— |
1,419 |
— |
||||
Devaluation of the Venezuelan Bolivar Fuerte |
— |
— |
357 |
— |
||||
Non-income tax contingency charge |
796 |
— |
796 |
— |
||||
Customer bankruptcy costs |
— |
98 |
— |
1,254 |
||||
CFO transition costs |
— |
— |
— |
609 |
||||
Adjusted EBITDA |
$ 20,978 |
$ 18,863 |
$ 89,618 |
$ 80,935 |
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that the Company's demand is largely derived from the demand for its customers' products, which subjects the Company to downturns in a customer's business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, future terrorist attacks and other acts of violence. Other factors could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.
Conference Call
As previously announced,
About Quaker
Quaker Chemical Corporation |
||||||||
Consolidated Statement of Income |
||||||||
(In thousands, except per share data) |
||||||||
(Unaudited) |
||||||||
Three Months Ended |
Twelve Months Ended |
|||||||
2013 |
2012 |
2013 |
2012 |
|||||
Net sales |
$ 184,297 |
$ 172,868 |
$ 729,395 |
$ 708,226 |
||||
Cost of goods sold |
119,134 |
113,714 |
468,320 |
469,515 |
||||
Gross profit |
65,163 |
59,154 |
261,075 |
238,711 |
||||
% |
35.4% |
34.2% |
35.8% |
33.7% |
||||
Selling, general and administrative expenses |
49,931 |
45,478 |
189,832 |
175,487 |
||||
Operating income |
15,232 |
13,676 |
71,243 |
63,224 |
||||
% |
8.3% |
7.9% |
9.8% |
8.9% |
||||
Other income, net |
1,557 |
2,886 |
3,519 |
3,415 |
||||
Interest expense |
(699) |
(924) |
(2,922) |
(4,283) |
||||
Interest income |
321 |
183 |
986 |
592 |
||||
Income before taxes and equity in net income of associated companies |
16,411 |
15,821 |
72,826 |
62,948 |
||||
Taxes on income before equity in net income of associated companies |
3,556 |
2,883 |
20,489 |
15,575 |
||||
12,855 |
12,938 |
52,337 |
47,373 |
|||||
Equity in net income of associated companies |
1,825 |
829 |
6,514 |
2,867 |
||||
Net income |
14,680 |
13,767 |
58,851 |
50,240 |
||||
Less: Net income attributable to noncontrolling interest |
594 |
760 |
2,512 |
2,835 |
||||
Net income attributable to Quaker Chemical Corporation |
$ 14,086 |
$ 13,007 |
$ 56,339 |
$ 47,405 |
||||
% |
7.6% |
7.5% |
7.7% |
6.7% |
||||
Per share data: |
||||||||
Net income attributable to Quaker Chemical Corporation Common Shareholders - basic |
$ 1.07 |
$ 0.99 |
$ 4.28 |
$ 3.64 |
||||
Net income attributable to Quaker Chemical Corporation Common Shareholders - diluted |
$ 1.07 |
$ 0.99 |
$ 4.27 |
$ 3.63 |
Quaker Chemical Corporation |
||||
Consolidated Balance Sheet |
||||
(In thousands, except par value and share amounts) |
||||
(Unaudited) |
||||
December 31, |
December 31, |
|||
2013 |
2012 |
|||
ASSETS |
||||
Current assets |
||||
Cash and cash equivalents |
$ 68,492 |
$ 32,547 |
||
Accounts receivable, net |
165,629 |
154,197 |
||
Inventories, net |
71,557 |
72,471 |
||
Current deferred tax assets |
7,826 |
6,401 |
||
Prepaid expenses and other current assets |
15,343 |
12,194 |
||
Total current assets |
328,847 |
277,810 |
||
Property, plant and equipment, net |
85,488 |
85,112 |
||
Goodwill |
58,151 |
59,169 |
||
Other intangible assets, net |
31,272 |
32,809 |
||
Investments in associated companies |
19,397 |
16,603 |
||
Non-current deferred income taxes |
24,724 |
30,673 |
||
Other assets |
36,267 |
34,458 |
||
Total assets |
$ 584,146 |
$ 536,634 |
||
LIABILITIES AND EQUITY |
||||
Current liabilities |
||||
Short-term borrowings and current portion of long-term debt |
$ 1,395 |
$ 1,468 |
||
Accounts payable |
72,281 |
67,586 |
||
Dividends payable |
3,299 |
3,208 |
||
Accrued compensation |
20,801 |
16,842 |
||
Accrued pension and postretirement benefits |
1,438 |
2,188 |
||
Current deferred tax liabilities |
1,057 |
253 |
||
Other current liabilities |
30,585 |
16,247 |
||
Total current liabilities |
130,856 |
107,792 |
||
Long-term debt |
17,321 |
30,000 |
||
Non-current deferred income taxes |
6,394 |
6,383 |
||
Non-current accrued pension and postretirement benefits |
37,006 |
49,916 |
||
Other non-current liabilities |
47,538 |
52,867 |
||
Total liabilities |
239,115 |
246,958 |
||
Equity |
||||
Common stock, $1 par value; authorized 30,000,000 shares; issued 2013 - 13,196,140 shares |
13,196 |
13,095 |
||
Capital in excess of par value |
99,038 |
94,470 |
||
Retained earnings |
258,620 |
215,390 |
||
Accumulated other comprehensive loss |
(34,700) |
(41,855) |
||
Total Quaker shareholders' equity |
336,154 |
281,100 |
||
Noncontrolling interest |
8,877 |
8,576 |
||
Total equity |
345,031 |
289,676 |
||
Total liabilities and equity |
$ 584,146 |
$ 536,634 |
||
Quaker Chemical Corporation |
||||
Consolidated Statement of Cash Flows |
||||
For the twelve months ended December 31, |
||||
(In thousands) |
||||
(Unaudited) |
||||
2013 |
2012 |
|||
Cash flows from operating activities |
||||
Net income |
$ 58,851 |
$ 50,240 |
||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||
Depreciation |
12,339 |
12,252 |
||
Amortization |
3,445 |
3,106 |
||
Equity in undistributed earnings of associated companies, net of dividends |
(4,162) |
(2,350) |
||
Deferred income taxes |
(30) |
2,354 |
||
Uncertain tax positions (non-deferred portion) |
(1,826) |
(1,407) |
||
Acquisition-related fair value adjustments |
200 |
(1,909) |
||
Deferred compensation and other, net |
(259) |
(156) |
||
Stock-based compensation |
4,161 |
3,807 |
||
Loss (gain) on disposal of property, plant and equipment |
200 |
(108) |
||
Insurance settlements realized |
(988) |
(1,391) |
||
Pension and other postretirement benefits |
862 |
(1,427) |
||
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions: |
||||
Accounts receivable |
(11,837) |
779 |
||
Inventories |
406 |
3,228 |
||
Prepaid expenses and other current assets |
(743) |
504 |
||
Accounts payable and accrued liabilities |
11,301 |
(2,562) |
||
Estimated taxes on income |
1,881 |
(2,067) |
||
Net cash provided by operating activities |
73,801 |
62,893 |
||
Cash flows from investing activities |
||||
Investments in property, plant and equipment |
(11,439) |
(12,735) |
||
Payments related to acquisitions, net of cash acquired |
(2,478) |
(5,635) |
||
Proceeds from disposition of assets |
513 |
245 |
||
Interest earned on an Insurance settlement |
52 |
69 |
||
Change in restricted cash, net |
936 |
1,322 |
||
Net cash used in investing activities |
(12,416) |
(16,734) |
||
Cash flows from financing activities |
||||
Net decrease in short-term borrowings |
- |
(315) |
||
Repayments of long-term debt |
(12,791) |
(17,632) |
||
Dividends paid |
(13,018) |
(12,616) |
||
Stock options exercised, other |
(307) |
(924) |
||
Excess tax benefit related to stock option exercises |
815 |
2,045 |
||
Distributions to noncontrolling shareholders |
(905) |
(1,099) |
||
Net cash used in financing activities |
(26,206) |
(30,541) |
||
Effect of exchange rate changes on cash |
766 |
20 |
||
Net increase in cash and cash equivalents |
35,945 |
15,638 |
||
Cash and cash equivalents at the beginning of the period |
32,547 |
16,909 |
||
Cash and cash equivalents at the end of the period |
$ 68,492 |
$ 32,547 |
||
SOURCE
Margaret M. Loebl, Vice President, Chief Financial Officer and Treasurer, loeblm@quakerchem.com, T. 610.832.4160